John Kilcoyne is the founder of JenaValve Technology. JenaValve Technology has raised $150M in total funding. Latest round: Series C.
John Kilcoyne is the CEO of JenaValve Technology, a medical device company that develops and manufactures transcatheter aortic valve replacement (TAVR) systems. The company has raised $150 million in financing, including a $100 million Series C and a $50 million equity round, to advance its Trilogy TAVR Solution and complete clinical trials for FDA approval.
Full founder directory · Investor directory · Company funding database · Fundraising library